Form 4 for JNJ Johnson & Johnson
Accepted 2022-02-17 06:01:01 ET · period of report 2022-02-14 · accession 0001225208-22-002373 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | +15.8K | 48.1K | +49% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | F - Tax | $165.89 | -6,242 | 41.8K | -13% | -$1.04M |
| DM | 2022-02-17 06:01 | 2022-02-14 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | A - Grant | $157.90 | +69.5K | 3,347 | New | +$10.97M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | -15.8K | 1,506 | -91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | M | A | 15,806 | $0.00 | 48,054.95 | D | — | — | (F1) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 6,242 | $165.89 | 41,812.95 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of Performance Share Units. |
| 3 | Derivative | Employee Stock Options (Right to Buy) | 2022-02-14 | A | A | 66,110 | $165.89 | 66,110 | D | — · 2025-02-14 to 2032-02-14 | 66,110 Common Stock | (F5) Awarded under Issuer's Long-Term Incentive Plan. (F5) Awarded under Issuer's Long-Term Incentive Plan. |
| 4 | Derivative | Restricted Share Units | 2022-02-14 | A | A | 3,347 | $0.00 | 3,347 | D | — · 2025-02-14 to — | 3,347 Common Stock | (F6) Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. (F6) Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. |
| 5 | Derivative | Performance Share Units | 2022-02-15 | M | D | 15,806 | $0.00 | 1,506 | D | — · 2022-02-11 to — | 15,806 Common Stock | (F7) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. (F7) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. |